#PCOR-ANZ annual report is out - bit.ly/39oFRhI 40000 men with population ascertainment across 2 countries. Kiwis lead Australians in the adoption of short course RT for #prostatecancer

We’re here to help with the USANZ- MOGA- CCA- SIU- and RANZCR-endorsed Australia and New Zealand Prostate Cancer Outcomes Registry #PCOR with 40000 men in our new annual report bit.ly/39oFRhI

Victorians @jgrummet lead the way in TP biopsies #PCOR-ANZ annual report is out - bit.ly/39oFRhI 40000 men with population ascertainment across 2 countries.

Pleased to have partnered with Dr Joseph Bucci and @pcfa to deliver a webinar for patients on LDR Brachytherapy. #brachytherapy #prostatecancer Brachytherapy for Prostate Cancer: Where does it fit in your journey? youtu.be/63eLUUzKMa0 via YouTube

And in the same OR as The Alfred #Thisisbrachytherapy case 1 in 1998 too! But it’s Dr Ong Wee Loon Ong leaving, not *my* final! He’s off to research, study, and train even more in Toronto in 2022 - and we’re sad to see him go 🥲

On 4 Feb, for 12 hours only, from 9am to 9pm your donation will be doubled by our generous matching donors until we hit our target of $400k. That means double the impact for life-saving cancer research. Register and don't miss Cancer Research Giving Day: bit.ly/3H7xCp8

We are the largest non-Government funder of competitive research in Victoria and rely on our generous, thoughtful and handsome donors to help the best researchers working to help people affected by cancer.

Smart, radiant #WomenWhoCurie, strong & lucent mentors lighting my way through #RadOnc training, sowing seeds of passion for #brachytherapy. Proud to be #WomenInSTEM on #IWD2022 #WomenInMedicine Jeremy Millar Sandra Turner Lucinda Morris Wee Loon Ong MPI Alfred Prostate

Research, by promoting the expansion of knowledge & of technological developments, is an essential means to improve cancer outcomes… Berger 50 years of radiotherapy research…. doi.org/10.1016/j.rado… RANZCR Targeting Cancer

Turns out The decisions made by funding bodies are pivotal in defining the direction taken by our field. doi.org/10.1016/j.rado… RANZCR Targeting Cancer

Pound-for-pound we’re the highest published around. Down here in ANZ per capita in RT we publish about 30% more than NAmerica, and 2xEurope. ‘Oceania is the most productive region… followed by North America, then Europe’ doi.org/10.1016/j.rado… RANZCR Targeting Cancer

Very pleased to present the 4th MARCAP analysis, "SANDSTORM" now live online at ascopubs.org/doi/full/10.12… Journal of Clinical Oncology (1/n)

Today we are announcing $1.9 m in Venture Grants, funding our best and brightest Vic researchers to find tomorrow's lifesaving #cancer treatments. #Research saves lives. Read more: cancervic.org.au/about/media-re…

🧵1/ Wide adoption of SABR for primary #kidneycancer is limited by long-term data. Online today The Lancet Oncology; 5-yr outcomes in 190 patients. 5% local failure rates, 95% cancer-specific survival. Thanks Elsevier for 50-day link: #radonc #kcsm sciencedirect.com/science/articl…

Hey, check it out, great new resource for Victorian cancer patients and their families. Todd Harper

Our annual Cancer In Victoria Report is the world's most up-to-date cancer incidence & mortality. There’s a clear message in the data. At the end of 2021, there were ~3,800 Victorians with cancer, not yet diagnosed. More: bit.ly/3HigkIC Don't Delay. Get Checked

Great work from Cancer Council Victoria

LAPERS (#EMBRACE) more reflective of ‘true’ late toxicities of #prostatebrachy considering severity duration and persistence of symptoms. Wee Loon Ong looked at new analysis of MPI Alfred Prostate men. doi.org/10.1016/j.brac…

this is perfection

And the team did a second case in the afternoon!